( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
Audited
UnAudited
Net Sales
1338.1
1534.6
1778.3
1481.6
Total Expenditure
1400.7
1610
1851.8
1634.8
PBIDT (Excl OI)
-62.60
-75.40
-73.5
-153.2
Other Income
33.1
15.6
67.6
8.3
Operating Profit
-29.5
-59.8
-5.89
-144.9
Exceptional Items
NA
NA
NA
NA
PBDT
-94.4
-121.3
-54.59
-199
Depreciation
47
45.4
40.6
40.8
Profit Before Tax
-141.4
-166.7
-95.19
-239.8
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-141.4
-166.7
-95.19
-239.8
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-141.4
-166.7
-95.19
-239.8
Minority Interest
NA
NA
NA
NA
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-141.4
-166.7
-95.2
-239.8
Equity Capital
167.4
167.4
167.4
167.4
Calculated EPS
-1.68
-1.99
-1.13
-2.86
Calculated EPS (Annualised)
-6.75
-7.96
-4.54
-11.45
No of Public Share Holdings
20960027
20960027
20960027
20319977
% of Public Share Holdings
25.04
25.04
25.04
24.27
PBIDTM% (Excl OI)
-4.67
-4.91
-4.13
-10.34
PBIDTM%
-2.20
-3.89
-0.33
-9.77
PBDTM%
-7.05
-7.90
-3.07
-13.43
PBTM%
-10.56
-10.86
-5.35
-16.18
PATM%
-10.56
-10.86
-5.35
-16.18